213 related articles for article (PubMed ID: 25416148)
1. Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis.
Thomas MM; Zhang Y; Mathew E; Kane KT; Maillard I; Pasca di Magliano M
BMC Cancer; 2014 Nov; 14():862. PubMed ID: 25416148
[TBL] [Abstract][Full Text] [Related]
2. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia.
De La O JP; Emerson LL; Goodman JL; Froebe SC; Illum BE; Curtis AB; Murtaugh LC
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18907-12. PubMed ID: 19028876
[TBL] [Abstract][Full Text] [Related]
3. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas.
Maier HJ; Wagner M; Schips TG; Salem HH; Baumann B; Wirth T
Oncogene; 2013 May; 32(21):2690-5. PubMed ID: 22751123
[TBL] [Abstract][Full Text] [Related]
4. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling pathway in pancreatic tumorigenesis.
Chung WC; Xu K
Adv Cancer Res; 2023; 159():1-36. PubMed ID: 37268393
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.
Maniati E; Bossard M; Cook N; Candido JB; Emami-Shahri N; Nedospasov SA; Balkwill FR; Tuveson DA; Hagemann T
J Clin Invest; 2011 Dec; 121(12):4685-99. PubMed ID: 22056382
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling in pancreatic cancer: oncogene or tumor suppressor?
Avila JL; Kissil JL
Trends Mol Med; 2013 May; 19(5):320-7. PubMed ID: 23545339
[TBL] [Abstract][Full Text] [Related]
8. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations.
Wong NK; Fuller M; Sung S; Wong F; Karsan A
Cancer Med; 2012 Oct; 1(2):105-13. PubMed ID: 23342261
[TBL] [Abstract][Full Text] [Related]
10. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling inhibition protects against LPS mediated osteolysis.
Goel PN; Egol AJ; Moharrer Y; Brandfield-Harvey B; Ahn J; Ashley JW
Biochem Biophys Res Commun; 2019 Aug; 515(4):538-543. PubMed ID: 31176486
[TBL] [Abstract][Full Text] [Related]
12. Canonical
Herrick DB; Guo Z; Jang W; Schnittke N; Schwob JE
J Neurosci; 2018 May; 38(21):5022-5037. PubMed ID: 29739871
[TBL] [Abstract][Full Text] [Related]
13. The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor.
Maillard I; Tu L; Sambandam A; Yashiro-Ohtani Y; Millholland J; Keeshan K; Shestova O; Xu L; Bhandoola A; Pear WS
J Exp Med; 2006 Oct; 203(10):2239-45. PubMed ID: 16966428
[TBL] [Abstract][Full Text] [Related]
14. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.
Osanyingbemi-Obidi J; Dobromilskaya I; Illei PB; Hann CL; Rudin CM
Mol Cancer Res; 2011 Dec; 9(12):1746-54. PubMed ID: 21994468
[TBL] [Abstract][Full Text] [Related]
15. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells.
Maillard I; Koch U; Dumortier A; Shestova O; Xu L; Sai H; Pross SE; Aster JC; Bhandoola A; Radtke F; Pear WS
Cell Stem Cell; 2008 Apr; 2(4):356-66. PubMed ID: 18397755
[TBL] [Abstract][Full Text] [Related]
16. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
Vega ME; Giroux V; Natsuizaka M; Liu M; Klein-Szanto AJ; Stairs DB; Nakagawa H; Wang KK; Wang TC; Lynch JP; Rustgi AK
Cell Cycle; 2014; 13(24):3857-66. PubMed ID: 25558829
[TBL] [Abstract][Full Text] [Related]
18. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Lee JC; Shin J; Baek KH
Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
[TBL] [Abstract][Full Text] [Related]
19. The repression of Notch signaling occurs via the destabilization of mastermind-like 1 by Mesp2 and is essential for somitogenesis.
Sasaki N; Kiso M; Kitagawa M; Saga Y
Development; 2011 Jan; 138(1):55-64. PubMed ID: 21098559
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.
Köchert K; Ullrich K; Kreher S; Aster JC; Kitagawa M; Jöhrens K; Anagnostopoulos I; Jundt F; Lamprecht B; Zimber-Strobl U; Stein H; Janz M; Dörken B; Mathas S
Oncogene; 2011 Apr; 30(15):1831-40. PubMed ID: 21119597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
